Skip to main content

3 Result(s)

within Elizabeth A Williamson Remove this filter Cancer Research Remove this filter

and

  1. No Access

    Article

    Resistance to the BCL-XL degrader DT2216 in T-cell acute lymphoblastic leukemia is rare and correlates with decreased BCL-XL proteolysis

    The BCL-2 family of anti-apoptotic proteins, BCL-2, BCL-XL and MCL-1, can mediate survival of some types of cancer. DT2216 is a PROteolysis-TArgeting Chimera (PROTAC) that degrades BCL-XL specifically and is i...

    Arunima Jaiswal, Aruna Jaiswal… in Cancer Chemotherapy and Pharmacology (2023)

  2. Article

    Open Access

    Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition

    Malignant pleural mesotheliomas (MPM) are most often surgically unresectable, and they respond poorly to current chemotherapy and radiation therapy. Between 23 and 64% of malignant pleural mesothelioma have so...

    Gayathri Srinivasan, Gurjit Singh Sidhu… in Cancer Chemotherapy and Pharmacology (2017)

    Download PDF (567 KB) View Article

  3. Article

    Open Access

    The DNA repair component Metnase regulates Chk1 stability

    Chk1 both arrests replication forks and enhances repair of DNA damage by phosphorylation of downstream effectors. Metnase (also termed SETMAR) is a SET histone methylase and transposase nuclease protein that p...

    Elizabeth A Williamson, Yuehan Wu, Sudha Singh, Michael Byrne, Justin Wray… in Cell Division (2014)

    Download PDF (481 KB) View Article